Pharmafile Logo
Pharmafocus logo
Advanced Search

Januvia

Showing 13 posts of 13 posts found.

Novo’s oral semaglutide beats Victoza and Januvia in diabetes

June 21, 2018
Research and Development Januvia, MSD, Novo Nordisk, Victoza, pharma, semaglutide

Novo Nordisk has released new data for its oral semaglutide diabetes therapy from two trials, showing that the GLP-1 analogue …

News
Januvia image

Merck diabetes drug gets CV trial boost

June 9, 2015
Research and Development, Sales and Marketing Januvia, Merck, cv, diabetes, sitagliptin

Merck’s diabetes drug Januvia has been given a boost following worries over side effects for patients after a trial revealed …

News

Sales forecasts leave Sovaldi top and Januvia lagging

May 23, 2014
Sales and Marketing Gilead, Januvia, Merck, diabetes, ep, hep C, sovaldi

Sovaldi has topped analysts’ estimates for future growth but Merck’s big-selling diabetes drug Januvia is falling by the wayside. This …

News
januvia image

MSD takes Januvia rap

July 9, 2013
Medical Communications, Sales and Marketing Januvia, MSD, Merck, PMCPA

Merck Sharp & Dohme has been censured by the PMCPA for failing to uphold standards in the way it promoted …

News

Diabetes prescriptions jump by 50% in England

August 15, 2012
Sales and Marketing Humalog, Januvia, NHS, diabetes, spending

Diabetes prescriptions in England have for the first time topped 40 million this year, a rise of nearly 50% compared …

News
FDA picture

FDA approves greener process for Januvia production

May 1, 2012
Manufacturing and Production Codexis, FDA, Januvia, Merck, manufacturing

The US Food and Drug Administration (FDA) has approved a new, more environmentally-friendly manufacturing process for Merck & Co’s diabetes …

News

Januvia gains renal impairment licence in UK

April 13, 2012
Sales and Marketing Januvia, MSD, Merck, diabetes, renal impairment

Merck’s Januvia has had its licence extended in the UK for patients with moderate to severe renal impairment. The drug …

News
Novo Nordisk HQ

Victoza superiority to Januvia made official by FDA

April 10, 2012
Medical Communications, Sales and Marketing Januvia, Merck, Novo Nordisk, Victoza, diabetes

Novo Nordisk is now able to claim superiority for its diabetes drug Victoza compared to Merck’s rival treatment Januvia.The US …

News
Merck image

Merck warned over missing Januvia safety study

March 13, 2012
Research and Development FDA, Januvia, Merck, study

Merck has been warned by the FDA that it must carry out a post-marketing safety study on diabetes treatments Januvia …

News

US approval for Merck’s Januvia-Zocor combination

October 10, 2011
Sales and Marketing Januvia, Juvisync, Zocor

US regulators have given the green light to the latest in Merck & Co’s stable of brands aimed at type …

News

Fresh scrutiny for new diabetes drugs

September 15, 2011
Sales and Marketing Byetta, GLP-1, Januvia, Merck, Novo Nordisk, Victoza, diabetes

Merck’s Januvia and Lilly’s Byetta face renewed safety questions this week as the European Association for the Study of Diabetes …

News

Januvia helps stabilise Merck sales

October 23, 2009
Sales and Marketing Januvia, Merck

 Merck has turned in stable figures for the third quarter of the year, with global sales up 2% on the …

News

Januvia launched in UK

April 25, 2007
Sales and Marketing Januvia, diabetes

Merck Sharp & Dohme has launched its first-in-class diabetes treatment Januvia in the UK. Januvia has been approved as an …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026